If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetcall Regulatory News (NET)

Share Price Information for Netcall (NET)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 87.00
Bid: 86.00
Ask: 88.00
Change: 0.00 (0.00%)
Spread: 2.00 (2.326%)
Open: 87.00
High: 87.00
Low: 87.00
Prev. Close: 87.00
NET Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Options, PDMR Dealing & TVR

24 Jan 2024 14:14

RNS Number : 8084A
Netcall PLC
24 January 2024

24 January 2024

NETCALL PLC

("Netcall", the "Company" or the "Group")

Exercise of Options, PDMR Dealing and Total Voting Rights

Netcall plc (AIM: NET), a leading customer engagement software provider, announces that it has issued and allotted 2,008,556 new ordinary shares of 5 pence each ("Ordinary Shares") following the exercise of share options by Henrik Bang, Chairman and James Ormondroyd, Chief Executive Officer of the Company, respectively of 1,266,657 and 741,899 Ordinary Shares.

In order to satisfy investor demand and to meet tax liabilities due, Mr Bang has sold 634,000 Ordinary Shares and Mr Ormondroyd has sold 371,000 Ordinary Shares, each at a price of 92.5 pence per Ordinary Share. In addition, Michael Jackson (Non-Executive Director) has sold 300,000 Ordinary Shares at a price of 92.5 pence per Ordinary Share.

Following the exercise of options, the issue of the 2,008,556 new Ordinary Shares and sale of 1,305,000 Ordinary Shares, the relevant director's shareholding is as follows:

· Mr Jackson's shareholding has decreased from 2,046,450 to 1,746,450 Ordinary Shares of 5 pence each, representing 1.07 per cent. of the issued share capital of the Company;

· Mr. Bang's shareholding has increased from 5,708,120 to 6,340,777 Ordinary Shares of 5 pence each, representing 3.88 per cent. of the issued share capital of the Company; and

· Mr. Ormondroyd's shareholding has increased from 2,721,705 to 3,092,604 Ordinary Shares of 5 pence each, representing 1.89 per cent. of the issued share capital of the Company;

Application has been made to the London Stock Exchange for the 2,008,556 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 30 January 2024.

The Company advises that, following Admission, the Company's issued share capital will be 165,140,809 Ordinary Shares which includes 1,869,181 Ordinary Shares which are held in treasury. As such the Company's total number of Ordinary Shares with voting rights is 163,271,628.

The above figure of 163,271,628 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

For further enquiries, please contact:

Netcall plc

Tel. +44 (0) 330 333 6100

James Ormondroyd, CEO

Henrik Bang, Non-Executive Chair

Richard Hughes, CFO

Canaccord Genuity Limited (Nominated Adviser and Broker)

Tel. +44 (0) 20 7523 8000

Simon Bridges / Andrew Potts

Singer Capital Markets (Joint Broker)

Tel. +44 (0) 20 7496 3000

Harry Gooden / Asha Chotai

Alma Strategic Communications

Tel. +44 (0) 20 3405 0205

Caroline Forde / Hilary Buchanan / Matthew Young

About Netcall

Netcall's Liberty software platform with Intelligent Automation and Customer Engagement solutions helps organisations digitally transform their businesses faster and more efficiently, empowering them to create a leaner, more customer-centric organisation.

Netcall's customers span enterprise, healthcare and government sectors. These include two-thirds of the NHS Acute Health Trusts and leading corporates including Legal and General, Lloyds Banking Group, Aon and Santander.

For further information, please go to www.netcall.com.

Prior to publication the information communicated in this announcement was deemed by the Company to constitute inside information for the purposes of article 7 of the Market Abuse Regulations (EU) No 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations No 2019/310 ('MAR'). With the publication of this announcement, this information is now considered to be in the public domain.

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Michael Jackson

2.

Reason for the Notification

a)

Position/status

Non Executive Director

b)

Initial notification/Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

b)

LEI

213800GZHEAA98QBJY98

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares

Identification code

GB0000060532

b)

Nature of the transaction

(a) Sale of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

(a)

92.5p

300,000

d)

Aggregated information:

Aggregated volume

Price

300,000 Ordinary Shares sold at a price of 92.5 pence per Ordinary Share

e)

Date of the transaction

24 January 2024

f)

Place of the transaction

London Stock Exchange (XLON)

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Henrik Bang

2.

Reason for the Notification

a)

Position/status

Chairman

b)

Initial notification/Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

b)

LEI

213800GZHEAA98QBJY98

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares

Identification code

GB0000060532

b)

Nature of the transaction

(a) Exercise of Options to acquire ordinary shares

(b) Sale of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

(a)

5p

1,266,657

(b)

92.5p

634,000

d)

Aggregated information:

Aggregated volume

Price

1,266,657 Ordinary Shares exercised at a price of 5 pence per Ordinary Share

634,000 Ordinary Shares sold at a price of 92.5 pence per Ordinary Share

e)

Date of the transaction

24 January 2024

f)

Place of the transaction

London Stock Exchange (XLON)

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

James Ormondroyd

2.

Reason for the Notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

b)

LEI

213800GZHEAA98QBJY98

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares

Identification code

GB0000060532

b)

Nature of the transaction

(a) Exercise of Options to acquire ordinary shares

(b) Sale of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

(a)

5p

741,899

(b)

92.5p

371,000

d)

Aggregated information:

Aggregated volume

Price

741,899 Ordinary Shares exercised at a price of 5 pence per Ordinary Share

371,000 Ordinary Shares sold at a price of 92.5 pence per Ordinary Share

e)

Date of the transaction

24 January 2024

f)

Place of the transaction

London Stock Exchange (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHBIMITMTBTBBI
Date   Source Headline
28th Sep 20184:48 pmRNSHolding(s) in Company
25th Sep 20187:00 amRNSNotice of Results
14th Aug 20187:00 amRNSMATS Contract Renewal
13th Aug 201810:48 amRNSChange of Registered Office
6th Aug 20187:00 amRNSCombined Liberty and MATS Contract Win
24th Jul 20187:00 amRNSTrading Update
25th Jun 20188:12 amRNSExercise of Options and Total Voting Rights
5th Jun 20187:00 amRNSContract Renewal
30th Apr 20182:51 pmRNSExercise of Options and Total Voting Rights
19th Mar 20183:31 pmRNSExercise of Options and Total Voting Rights
19th Mar 20189:45 amRNSDirector/PDMR Shareholding
7th Mar 20187:00 amRNSHalf-year Report
29th Jan 20187:00 amRNSTrading Update and Notice of Results
11th Jan 201811:59 amRNSHolding(s) in Company
5th Dec 201712:29 pmRNSExercise of Options and Total Voting Rights
23rd Nov 20172:35 pmRNSResult of AGM
23rd Nov 20177:00 amRNSAGM Statement
26th Oct 20172:32 pmRNSNotice of AGM
13th Oct 20172:12 pmRNSHolding(s) in Company
26th Sep 20177:00 amRNSFinal Results
20th Sep 201710:06 amRNSHolding(s) in Company
12th Sep 20177:00 amRNSNotice of Results
7th Aug 20177:00 amRNSAcquisition
3rd May 20178:15 amRNSHolding(s) in Company
30th Mar 20175:46 pmRNSHolding(s) in Company
21st Feb 20177:00 amRNSHalf-year Report
3rd Feb 201711:53 amRNSHolding(s) in Company
26th Jan 20177:00 amRNSTrading Update and Notice of Results
20th Dec 20167:00 amRNSExercise of Options and Total Voting Rights
5th Dec 20168:45 amRNSDirector/PDMR Shareholding
24th Nov 20165:24 pmRNSResult of AGM
24th Nov 20167:00 amRNSAGM Statement
1st Nov 20165:11 pmRNSNotice of AGM
27th Sep 20167:01 amRNS£1.5m Contract Win
27th Sep 20167:00 amRNSFinal Results
1st Sep 20167:00 amRNSNotice of Results
22nd Aug 20168:26 amRNSHolding(s) in Company
20th Jul 20167:00 amRNSTrading Update
20th May 20163:08 pmRNSDirector Dealing
19th Apr 20163:13 pmRNSHolding(s) in Company
16th Mar 20161:29 pmRNSHolding(s) in Company
23rd Feb 20167:00 amRNSHalf Yearly Report
25th Jan 20167:00 amRNSTrading Statement and Notice of Results
9th Dec 20157:00 amRNSContract Win
30th Nov 201511:55 amRNSExercise of Options & Total Voting Rights
26th Nov 20151:31 pmRNSResult of AGM
26th Nov 20157:01 amRNSContract Win
26th Nov 20157:00 amRNSAGM Statement
30th Oct 20154:14 pmRNSPosting of Notice of AGM
21st Oct 201512:40 pmRNSExercise of Options and Director Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.